Session
Number

0000
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500

TABLE OF CONTENTS

If you can read this text, your browser does not support Cascading Style Sheets. Although not essential for using this CD-ROM, you may wish to upgrade your browser to a more recent version.

Scroll down or use the links located to your right to jump to a new location in this index.

Click on a blue handout title to view that handout. Titles in black were not submitted.

Thursday, February 22, 2007

7:20am – 5:30pm

0001 – Military Allergy/Immunology Program – 21st Annual Harold S. Nelson Allergy/Immunology Symposium

Welcome and Overview

Margaret Yacovone MD

Emerging Infectious Diseases for the Immunologist

Theodore Cieslak MD

Imported Fire Ants

Theodore Freeman MD FAAAAI

Vaccine Healthcare Center Update

Renata Engler MD FAAAAI

Military Aeroallergen Extract Laboratory Updates

Michael Nelson MD PhD FAAAAI

Military Allergy/Immunology Program – 21st Annual Harold S. Nelson Allergy/Immunology Symposium

Ronald England MD

Consultants to the Surgeons General Update – Air Force

Diane Napoli MD

Consultants to the Surgeons General Update – Army

Bryan Martin DO FAAAAI

Consultants to the Surgeons General Update – Navy

Jay Montgomery MD FAAAAI

Friday, February 23, 2007

7:00 – 10:30am

1001 – FIT Breakfast Symposium

Mast Cell Biology

Joshua Boyce MD FAAAAI

Mast Cells in Human Disease

Dean Metcalfe MD FAAAAI

Introductory Remarks

Caroline Horner MD

The "Basics" of Adhesion Molecules

Klaus Ley MD

Anti – Adhesion Molecule Therapy in Allergic Disease

Stephen Holgate MD DSc FAAAAI

10:40 – 11:50am

1002 – FIT Morning Symposium

Aspirin Sensitivity

Donald Stevenson MD FAAAAI

Rhinosinusitis: Diagnosis and Treatment

Daniel Hamilos MD

12:15 – 1:45pm

1003 – FIT Lunch Symposium

AAP – SOAI Presentation

Paul Williams MD FAAAAI

Academia

Ana MacDowell MD

Academia

Jordan Orange MD PhD FAAAAI

Private Practice

Harvey Leo MD

7:00 – 8:30am

1011 – Clinical Research (CR) Workshop: Site and Investigator Selection

Site and Investigator Selection

Carrie D 'Andrea

1012 – Clinical Research (CR) Workshop: FDA Audits

The Clinical Site and IRB Perspectives on FDA Audits

Andrea Buchmeier CCRC

The FDA Perspective on Auditing a Clinical Trial Site Presentation

Allen Hall CSO

1013 – Clinical Research (CR) Workshop: Ethics in Clinical Research

Clinical Research (CR) Workshop: Ethics in Clinical Research

Eli Meltzer MD FAAAAI

Clinical Research (CR) Workshop: Ethics in Clinical Research

Caroline Gallet LVN CCRC

1014 – Clinical Research (CR) Workshop: Is Your Investigative Site in Compliance with Good Clinical Practice

Clinical Research (CR) Workshop: Is Your Investigative Site in Compliance with Good Clinical Practice

Anjuli Nayak MD FAAAAI

9:00am – 12:00pm

1101 – Understanding the Genetic Basis of Asthma and Allergy Susceptibility and Treatment (Part 1)

Importance of Phenotype Assessment in Genetic Studies: The Coast Study

Robert Lemanske MD FAAAAI

New Approaches in Family and Population Studies in Allergy and Asthma

Deborah Meyers PhD FAAAAI

Gene Identification and Expression Studies in Allergy and Asthma

Juha Kere

Gene – Environment Interactions: Specific Lessons from the Cincinnati Birth Cohort Study

Gurjit Khurana Hershey MD PhD FAAAAI

1102 – Developing Clinical Skills to Promote Adherence and Maximize Asthma Outcomes (Part I)

Overview: Why Are Patients Nonadherent?

Bruce Bender PhD FAAAAI

Clinical Management Strategies to Promote Adherence of Pediatric Asthma Patients and Families

Cynthia Rand PhD

Communication Skills That Will Yield Positive Outcomes

Andrew Weinstein MD FAAAAI

The Role of Motivational Interviewing to Help Guide Patients to Favorable Asthma Management Actions

Belinda Borrelli PhD

The Value of Adherence Monitoring Strategies for Both Low and High – Risk Patients

Henry Milgrom MD FAAAAI

1103 – Protective Effects of Infections and Microbial Exposures on Allergic Diseases

Epidemiology of Infections and Allergic Diseases

Andrew Liu MD FAAAAI

Role of Gastrointestinal Microflora in Allergic Disease Pathogenesis

Maria Jenmalm PhD

Oral Bacteria and Allergic Diseases

Samuel Arbes DDS MPH PhD

Relationship Between Microbial Exposures and Allergic Disease: Evidence from Animal Models

Mairi Noverr PhD

Immunological Effects of Infections and Microbial Exposures

Dale Umetsu MD PhD FAAAAI

Probiotics and Other Therapeutic Strategies

Sonia Michail MD

1104 – Difficult Cases (Part One)

Food Allergy

Fred (Dan) Atkins MD FAAAAI

Difficult Cases (Part One)

Adina Knight MD

Urticaria/Dermatology

Ana MacDowell MD

Difficult Cases (Part One)

Ronald Simon MD FAAAAI

Allergy Immunotherapy Vaccine Reaction

Michael Nelson MD PhD FAAAAI

Difficult Cases (Part One)

Rajiv Arora MD

Esophageal Gastrointestinal Diseases

Jonathan Spergel MD PhD FAAAAI

Difficult Cases (Part One)

Seema Aceves MD PhD

9:00am – 5:00pm

1121 – Basic Aeroallergen Course

Introduction to Fungal Aerobiology

W. Elliott Horner PhD FAAAAI

Fungal Spore Morphology

Estelle Levetin PhD FAAAAI

Fundamentals of Air Sampling

Estelle Levetin PhD FAAAAI

Introduction to Pollen Aerobiology

William Solomon MD FAAAAI

Pollen Morphology

John Shane PhD

9:00am – 12:00pm

1131 – NIAID Morning Symposium: Dendritic Cells

Moderator

Matthew Fenton PhD FAAAAI

Dendritic Cells and Immune Memory

Bali Pulendran PhD

Function of Plasmacytoid Dendritic Cells

Giorgio Trinchieri MD

Modulation of Dendritic Cell Trafficking to and From the Airways

Gwendalyn Randolph MD

T Cell Stimulation or Suppression by Dendritic Cells Competent to Express Indoleamine 2,3 Dioxygenase

Andrew Mellor PhD

NKT Cell Dendritic Cell Interactions

Mitchell Kronenberg MD

1141 – Clinical Research (CR) Symposium, Part 1: Biotechnology: From Bench to Bedside

Basic Immunology of Biotech Molecules in Clinical Trials: Their Clinical Efficacy and Safety

Anjuli Nayak MD FAAAAI

Nanotechnology and the Future of Clinical Drug Research

Lawrence McDermott MD

Is Your Site in Compliance with Biotechnology Research?

Karri Eimer CCRC

9:00 – 11:00am

1151 – Medical Administrators (MA) Morning Symposium: Risk Management and the Medical Practice

Medical Administrators (MA) Morning Symposium: Risk Management and the Medical Practice

Denise Yarborough Esquire

8:00am – 6:00pm

1161 – Advanced Practice Course For Allied Health Professionals

Moderator

Don Cui PA AE – C

Diagnosis and Management of Asthma: Case Based

Kathleen Conboy – Ellis NP PhD AE – C FAAAAI

Diagnosis and Management of Rhinosinusitis: Case Based

Jeanette Arnold NP

Diagnosis and Management of Stinging Insect Allergy: Case Based

Marietta King NP

Allergy Immunotherapy

Gabriel Ortiz MPAS PA – C

Advanced Practice Course For Allied Health Professionals

Christine Wagner FNP AE – C

Advanced Practice Course For Allied Health Professionals

Melanie Gleason PA

Spirometry Workshop: Case Based

B. Gwen Carlton RN MSN NP

Navigating the AAAAI Annual Meeting

B. Gwen Carlton RN MSN NP

Advanced Practice Course For Allied Health Professionals

Jeanette Arnold NP

Advanced Practice Course For Allied Health Professionals

Kathleen Conboy – Ellis NP PhD AE – C FAAAAI

Diagnosis and Management of Acute & Chronic Urticaria/Angioedema: Case Based

Christine Wagner FNP AE – C

Atopic/Contact Dermatitis: Case Based:

Melanie Gleason PA

Advanced Practice Course For Allied Health Professionals

Gabriel Ortiz MPAS PA – C

7:30 – 11:40am

1181 – ST*AR Morning Symposium

Can Biomedical Research Reduce the Morbidity and Mortality from Allergy and Asthma?

William Busse MD FAAAAI

Molecular Mechanisms of Allergic Inflammation

Robert Schleimer PhD

Welcome from the AAAAI President

Thomas A. Platts – Mills MD PhD FAAAAI

The Identification of Key Genes Regulating the Allergic Inflammatory Response

Kathleen Barnes PhD FAAAAI

The Influence of the Innate Immune Response on the Adaptive Allergic Response: Mast Cells

Stephen Galli MD

1481 – Interactive Lunch Session

Research Opportunities for PhDs in Allergy/Asthma Research: NIH

Alkis Togias MD FAAAAI

12:15 – 1:45pm

1501 – Clinical Research (CR) Workshop: The ABCs of Clinical Research

Clinical Research (CR) Workshop: The ABCs of Clinical Research

Mary Baliker BS

1502 – Clinical Research (CR) Workshop: How Do You Identify, Develop and Retain Your CRC?

The University Perspective

Kim Mudd RN

The Private Research Center Perspective

Cheryl Koff Bernstein RN BSN CCRC

1503 – Clinical Research (CR) Workshop: Pediatric Clinical Trials: Are You Ready?

Clinical Research (CR) Workshop: Pediatric Clinical Trials: Are You Ready?

Brian Berendts RN BSN CCRC

Clinical Research (CR) Workshop: Pediatric Clinical Trials: Are You Ready?

Kathleen Harden RN BSN CCRC

1504 – Clinical Research (CR) Workshop: Are You Prepared for the Future of Clinical Research?

Asthma and Inflammatory Testing: What 's New and What 's on the Horizon?

Karen Murphy BS RRT CCRC

Diversifying Your Clinical Research Center

Michael Noonan MD

1505 – Clinical Research (CR) Workshop: Are You Thinking About Starting Clinical Research?

Clinical Research (CR) Workshop: Are You Thinking About Starting Clinical Research?

Jonathan Matz MD FAAAAI

2:00 – 5:00pm

1601 – Understanding the Genetic Basis of Asthma and Allergy Susceptibility and Treatment (Part 2)

Applying Microarrays to Complex Diseases

Wei Wu PhD

Pharmacogenetic Approaches in Allergy and Asthma

Eugene Bleecker MD FAAAAI

Understanding Beta2 Adrenergic Receptor Function and Signaling

Raymond Penn MD

Genetic Analysis of Populations to Understand the Pathophysiology of Atopy and Asthma

William Cookson PhD

The Nuts and Bolts of Genome – Wide Association Studies

Nancy Cox PhD

1602 – Developing Clinical Skills to Promote Adherence and Maximize Asthma Outcomes (Part 2)

Workshop 1: Techniques to Apply to Patients Who are Ready to Change and Sustain Change

Cynthia Rand PhD

Workshop 1: Techniques to Apply to Patients Who are Ready to Change and Sustain Change

Stuart Tousman PhD

Workshop 1: Techniques to Apply to Patients Who are Ready to Change and Sustain Change

Chitra Dinakar MD FAAAAI

Workshop 1: Techniques to Apply to Patients Who are Ready to Change and Sustain Change

Henry Milgrom MD FAAAAI

Workshop 2: Motivating Patients Who are Reluctant to Change?

Andrew Weinstein MD FAAAAI

Workshop 2: Motivating Patients Who are Reluctant to Change?

Belinda Borrelli PhD

1603 – Environmental Effects on Allergic Respiratory Diseases

Risk Factor for Asthma Among Lower Socio – Economic Groups in Baltimore

Elizabeth Matsui MD

Endotoxin Exposure in Homes and in the Workplace: For Better or Worse?

Matthew Perzanowski PhD

Cockroach Allergen and Asthma Morbidity: Results from NCICAS and ICAS

Wayne Morgan MD

Successful Cockroach Allergen Remediation and Control

Samuel Arbes DDS MPH PhD

Gene – Environment Interactions Influencing the Development of Allergic Respiratory Disease

Kathleen Barnes PhD FAAAAI

Multiplex Technology: New Tools for Exposure Assessment and Allergen Specific IgE

Martin Chapman PhD FAAAAI

1604 – Difficult Cases: (Part 2)

Latex, Occupational and Miscellaneous Allergies

Mohamed Yassin MD FAAAAI

Difficult Cases: (Part 2)

Todd Rambasek MD

Penicillin Allergy

Eric Macy MD FAAAAI

Difficult Cases: (Part 2)

Caroline Horner MD

Rhinitis/Sinusitis/Conjunctivitis

Brian Smart MD FAAAAI

Difficult Cases: (Part 2)

Karen DeMuth MD

Host Defense Defects

Steven Holland MD

Difficult Cases: (Part 2)

Harvey Leo MD

Pediatric Asthma

Leonard Bacharier MD FAAAAI

Difficult Cases: (Part 2)

Gloria Akan MD

1605 – Allergy Diagnostics and Immunotherapy: The Nuts and Bolts of an Allergy Practice

Allergy Diagnostic Testing: Proper Technique, Interpretation and Staff Training and in vitro Allergy Testing: The Wave of the Future? Is There a Role (room) for Allergy Laboratory Tests in the Allergist 's Office?

John Oppenheimer MD

The Business Side of Medicine: Immunotherapy and Allergy Diagnostic Coding and Documentation: OSHA, CLIA, HIPPA and the Alphabet Soup of Government Regulations

Gary Gross MD FAAAAI

Allergen Immunotherapy, "Conventional" Immunotherapy: Preparing Effective Immunotherapy Vaccines: What Does it Take?

Harold Nelson MD FAAAAI

Immunotherapy of the Future: Monitoring Efficacy with in vitro Tests, Alternative Immunotherapy Routes and Formulations Around the World: Future and Present Use

Jay Portnoy MD FAAAAI

1606 – Endoscopic Techniques in Treatment of Sinusitis: Both Pre – and Post – Surgical

Anatomy, Radiology, Culture Techniques and Endoscopic Videos in Sinusitis Patients Without Having Surgery

Wellington Tichenor MD

Anatomy, Radiology, Culture Techniques and Endoscopic Videos in Sinusitis Patients Without Having Surgery

David Sherris MD

Anatomy, Radiology, Culture Techniques and Endoscopic Videos in Sinusitis Patients Without Having Surgery

S. James Zinreich MD

Surgery Video – Revision Surgery Video, Endoscopic Videos in Post – Surgical Patients, Case Management Studies

Wellington Tichenor MD

Surgery Video – Revision Surgery Video, Endoscopic Videos in Post – Surgical Patients, Case Management Studies

David Sherris MD

Surgery Video – Revision Surgery Video, Endoscopic Videos in Post – Surgical Patients, Case Management Studies

S. James Zinreich MD

1607 – Set Up & Operation of a Burkard Pollen/Spore Station

Set Up & Operation of a Burkard Pollen/Spore Station

James Anderson MLT

Set Up & Operation of a Burkard Pollen/Spore Station

Boyce Hornberger MD FAAAAI

1608 – Allergic and Immunologic Skin Disorders

Atopic Dermatitis: Etiology from Within

Donald Leung MD PhD FAAAAI

Food Allergen in Atopic Dermatitis

Hugh Sampson MD FAAAAI

Inhalants and Airborne Irritants and the Atopy Patch Test

Judith Woodfolk MBChB PhD FAAAAI

Autoimmune Urticaria and Angioedema: Update on Diagnosis and Treatment

Sarbjit Saini MD FAAAAI

Contact Dermatitis

Luz Fonacier MD FAAAAI

1621 – Food Allergy is an International Disease: Regional Differences from Around the World

Common and Specific Food Allergens in Asia

Adrian Wu MD

Food Allergy in Latin America

Cristina Jacob PhD

Hot Topics of Food Allergy in Europe

Barbara Ballmer MD

Sesame Allergy in Middle East

Menachem Rottem MD FAAAAI

Peanut Allergy in USA

Scott Sicherer MD FAAAAI

Countermeasures Against Food Allergy in Japan

Motohiro Ebisawa MD PhD FAAAAI

1631 – NIAID Afternoon Symposium: Immunologic Basis of Food Allergy

Animal Models of Eosinophilic Gastrointestinal Disease and Food Allergy

Marc Rothenberg MD PhD FAAAAI

Genetics of Food Allergy

Kathleen Barnes PhD FAAAAI

Pathophysiology of Food – Induced Anaphylaxis

Fred Finkelman MD

Mechanisms of Innate and Adaptive Immunity to Food Allergens

Wayne Shreffler MD

High Dose Food Allergen in Infancy to Prevent Food Allergy

Gideon Lack MD

New Therapeutics for Food Allergy

Donald Leung MD PhD FAAAAI

1641 – Clinical Research (CR) Symposium: All That Glitters is Not Gold: What Can Go Wrong in Clinical Trials

Is Your Clinical Site Financially Successful?

Cheryl Bernstein RN BSN CCRC

I Have a Contract and I 'm Indemnified so I 'm OK.....or Am I?

Orly Rumberg Esq

Clinical Trial Jeopardy

Michael Welch MD FAAAAI

Clinical Trial Jeopardy

Caroline Gallet LVN CCRC

Clinical Trial Jeopardy

Cheryl Lutz MT(ASCP) CCRC

2:00 – 4:00pm

1651 – Medical Administrators (MA) Afternoon Symposium: Coding Update for the Allergy Practice

Medical Administrators (MA) Afternoon Symposium: Coding Update for the Allergy Practice

Teresa Thompson CPC CMSCS CCC

1671 – Launching a Career in Academic Allergy/Immunology

Preparation for an Academic Center

Bruce Bochner MD FAAAAI

Finding an Academic Position

Kathleen Sullivan MD PhD

Initial Steps for Success

Andrew Liu MD FAAAAI

Launching a Career in Academic Allergy/Immunology

Syeda Inamdar MD

Launching a Career in Academic Allergy/Immunology

Andrew MacGinnitie MD PhD

Launching a Career in Academic Allergy/Immunology

Vivian Hernandez – Trujillo MD

Launching a Career in Academic Allergy/Immunology

David Huston MD FAAAAI

Launching a Career in Academic Allergy/Immunology

Charlotte Cunningham – Rundles MD PhD FAAAAI

Launching a Career in Academic Allergy/Immunology

Andrew Liu MD FAAAAI

6:30 – 8:30pm

1901 – Spectrum of Satisfaction in the Treatment of Allergic Rhinitis

Allergic Rhinitis: The Burden of the Disease

William Storms MD FAAAAI

Pathophysiology of Allergic Rhinitis and Comorbid Conditions

Eli Meltzer MD FAAAAI

Current and Emerging Therapies: Achieving Optimal Results

William Berger MD, MBA

1902 – CSI for Chronic Idiopathic Urticaria: Uncovering a Path of Relief for Our Youngest Patients

Pathophysiology of Chronic Idiopathic Urticaria: Uncovering the Evidence

Allen Kaplan MD FAAAAI

Clinical Effects and Impact on the Pediatric Patient: Investigating Critical Issues in Untreated Chronic Idiopathic Urticaria?

Craig Jones MD

Optimizing Pediatric Diagnosis and Treatment Approaches in Chronic Idiopathic Urticaria: Profiling Your Patient and Therapy Options

Michael Blaiss MD FAAAAI

1903 – Nasal Steroids: Understanding the Differences

Nasal Steroid Options: How Do They Differ?

Lanny Rosenwasser MD

Evaluating Safety of Intranasal Steroids

Ketan Sheth MD MBA FAAAAI

Assessing Patient Control

Rohit Katial MD FAAAAI

1904 – Hereditary and Acquired Angioedema

Pathophysiology of Angioedema

Alvin Davis MD

The Differential Diagnosis and Current Management of Angioedema

Michael Frank MD FAAAAI

Hereditary Angioedema: New Treatments in Sight?

Marco Cicardi MD

Saturday, February 24, 2007

7:00 – 8:00am

2001 – Pay for Performance: What It Means for the Practicing Allergist

Pay for Performance: What It Means for the Practicing Allergist

Donald Aaronson MD FAAAAI

Pay for Performance: What It Means for the Practicing Allergist

Michael Blaiss MD FAAAAI

Pay for Performance: What It Means for the Practicing Allergist

Michael Schatz MD MS FAAAAI

2011 – Mast Cell and Basophil Phenotypic Aberrations and Their Potential Role in "Idiopathic" or IgE – Independent Allergic Diseases

Mast Cell and Basophil Phenotypic Aberrations and Their Potential Role in "Idiopathic" or IgE – Independent Allergic Diseases

Leslie Grammer MD

Mast Cell and Basophil Phenotypic Aberrations and Their Potential Role in "Idiopathic" or IgE – Independent Allergic Diseases

Richard Stevens PhD FAAAAI

2012 – Aspirin Exacerbated Respiratory Disease (AERD) and Other NSAID Reactions

Aspirin Exacerbated Respiratory Disease (AERD) and Other NSAID Reactions

Katharine Woessner MD FAAAAI

Aspirin Exacerbated Respiratory Disease (AERD) and Other NSAID Reactions

Andrew Szczeklik MD PhD

2013 – What is the Role of Leukotriene Antagonists in Respiratory Disease?

What is the Role of Leukotriene Antagonists in Respiratory Disease?

Sally Wenzel MD FAAAAI

What is the Role of Leukotriene Antagonists in Respiratory Disease?

Leslie Hendeles PharmD

2014 – Environmental Control for Management of Allergic Asthma

Environmental Control for Management of Allergic Asthma

Pedro Avila MD

Environmental Control for Management of Allergic Asthma

Carol Saltoun MD

2015 – Evidence – Based Use of IVIG in PID

Evidence – Based Use of IVIG in PID

Charlotte Cunningham – Rundles MD PhD FAAAAI

Evidence – Based Use of IVIG in PID

Javier Chinen MD PhD

2016 – Exposure to Bioaerosals: Does it Drive the Allergic Process?

Exposure to Bioaerosals: Does it Drive the Allergic Process?

Neil Alexis PhD

Exposure to Bioaerosals: Does it Drive the Allergic Process?

Karin Pacheco MD MSPH FAAAAI

2017 – Insights Gained From the Study of Toll – Like Receptors

Insights Gained From the Study of Toll – Like Receptors

David Broide MB ChB FAAAAI

Insights Gained From the Study of Toll – Like Receptors

Stuart Turvey MD PhD

2018 – Assessment of Airway Inflammation Using FENO and Exhaled Breath Condensate

Assessment of Airway Inflammation Using FENO and Exhaled Breath Condensate

Philip Silkoff MD

Assessment of Airway Inflammation Using FENO and Exhaled Breath Condensate

John Hunt MD FAAAAI

2019 – Diagnostic Tests for Food Allergy: Skin, CAP RAST, Oral Challenge

Diagnostic Tests for Food Allergy: Skin, CAP RAST, Oral Challenge

Laurie Smith MD FAAAAI

Diagnostic Tests for Food Allergy: Skin, CAP RAST, Oral Challenge

Robert Hamilton PhD FAAAAI

2020 – When to Start and Stop Venom Immunotherapy: Challenging Cases

When to Start and Stop Venom Immunotherapy: Challenging Cases

David Golden MD FAAAAI

When to Start and Stop Venom Immunotherapy: Challenging Cases

Robert Reisman MD FAAAAI

2021 – Journal Club: High Impact Publications for Health Care Education, Delivery and Quality

Journal Club: High Impact Publications for Health Care Education, Delivery and Quality

Henry Milgrom MD FAAAAI

Journal Club: High Impact Publications for Health Care Education, Delivery and Quality

Chitra Dinakar MD FAAAAI

2022 – Bronchial Hyper – Responsiveness in Asthma: Insights Into New Signaling Pathways

Bronchial Hyper – Responsiveness in Asthma: Insights Into New Signaling Pathways

Yassine Amrani PhD

Bronchial Hyper – Responsiveness in Asthma: Insights Into New Signaling Pathways

Abdelilah Soussi Gounni PhD

2023 – The Role of Adenosine and Adenine Nucleotides in Asthma and Cough

The Role of Adenosine and Adenine Nucleotides in Asthma and Cough

Edward Schulman MD FAAAAI

The Role of Adenosine and Adenine Nucleotides in Asthma and Cough

Michael Blackburn MD

The Role of Adenosine and Adenine Nucleotides in Asthma and Cough

Eva Morschl PhD

2024 – Sublingual Immunotherapy: Whom and How?

Sublingual Immunotherapy: Whom and How?

Anthony Frew MD FAAAAI

Sublingual Immunotherapy: Whom and How?

Giovanni Passalacqua MD

2025 – Cytokines and Growth Factors in Ocular Disorders

Cytokines and Growth Factors in Ocular Disorders

Andrea Leonardi MD

Cytokines and Growth Factors in Ocular Disorders

Andrea Keane – Myers PhD

7:00 – 8:15am

2031 – Allergy and Asthma for the Health Care Professional (AAHCP) Symposium: Controversies and Opportunities in Management of Moderate to Severe Persistent Asthma

Pro

Michael Wechsler MD MMSc

Con

Robert Lemanske MD FAAAAI

2041 – Medical Administrators (MA) Symposium: Staff Recruitment and Retention

Medical Administrators (MA) Symposium: Staff Recruitment and Retention

Diane French MPA

8:15 – 9:45am

2101 – Immunopathogenesis of Asthma

TSLP: The Master Switch of Allergic Inflammation

Yong – Jun Liu MD PhD

Role of Oxidative Stress by Particulate Air Pollution in Asthma Exacerbations

Andre Nel MD PhD

Role of CD – 1 Restricted NKT Cells in Airway Inflammation and Asthma

Omid Akbari PhD

10:45am – 12:00pm

2301 – New Vaccines: Not Just For Children

Preventing Shingles and Post – Herpetic Neuralgia with Herpes Zoster Vaccine

Adriana Weinberg MD

Adverse Reactions to Vaccines Revealed in Military Populations

Renata Engler MD FAAAAI

HPV Vaccines: Promise and Problems

Richard Schlegel MD PhD

2302 – Bench to Bedside: Atopic Dermatitis

Cutaneous Defense Mechanisms

Victor Nizet MD

Genetics and Epigenetics of AD

William Cookson PhD

Therapeutic Protocols with Immunomodulators for AD

Lawrence Eichenfield MD

2303 – Mast Cells: Pivotal Regulators of Host Defense

Mast Cells and Host Response to Bacterial Pathogens

Soman Abraham PhD

Antigen – Independent Effects of IgE on Mast Cells

Hans Oettgen MD PhD FAAAAI

Mast Cells in Inflammatory Arthritis

David Lee MD PhD

2304 – Non – Allergic Asthma: Searching for Causes?

Respiratory Viruses: Causes or Aggravates?

R. Stokes Peebles MD FAAAAI

Does Early Exposure to Environmental Tobacco Smoke Contribute to Development of Asthma?

Mario Castro MD MPH

Non – Viral Infections: Causes or Aggravates?

Monica Kraft MD

2305 – Air Pollutants as Adjuvants in Allergic Diseases and Asthma: A New Era for the Allergy Specialty

What is the Contribution of Air Pollution to the Causation of Allergic Disease and Asthma?

Frank Gilliland MD PhD

The Role of Air Pollution Particles as a Potent Adjuvant that Causes Allergic Disease and Asthma?

David Diaz – Sanchez PhD

Can Adverse Respiratory Health Effects of Air Pollutants be Prevented?

Robert Devlin PhD

2306 – Medical Informatics and the A/I Specialty

Translational Bioinformatics: From Research to Care

Atul Butte MD PhD

Electronic Medical Health Records and Major Directions for Applications

Paul Tang MD

The Use of Computer Systems to Improve Patient Care: Focus on Safety and Quality

Eric Poon MD MPH

2307 – Allergies of the EYE in The Eyes of The Allergist

The Red Eye: Allergy, Dry or Hyperreactive?

Sergio Bonini MD

Conjunctival Challenge – A Clinical as Well as a Research Tool for the Allergist?

Andrea Leonardi MD

2311 – Allergy and Asthma for the Health Care Professional (AAHCP) Symposium: Chronic Cough: Sorting Out a Common Topic

Adults

Sheldon Spector MD FAAAAI

Children

Gary Rachelefsky MD FAAAAI

2321 – Medical Administrators (MA) Morning Symposium: Information Technology: Enhancing Clinical Operations

Medical Administrators (MA) Morning Symposium: Information Technology: Enhancing Clinical Operations

Rosemarie Nelson MS

12:30 – 1:30pm

2501 – ADT State–of–the–Art: Asthma Immunopathogenesis: A Pathway For Future Therapy

ADT State–of–the–Art: Asthma Immunopathogenesis: A Pathway For Future Therapy

Dale Umetsu MD PhD FAAAAI

2502 – BCI State–of–the–Art: Pathogen Recognition Receptors in Inflammation and Immunity

Modulating Vaccine Responses with Dendritic Cells and Pathogen Recognition Receptors

Bali Pulendran PhD

Caterpillers R ' Us: Novel Regulators of Inflammation and Apoptosis Preserved from Plants to Humans

Jenny Ting PhD

2503 – EORD State–of–the–Art: Gene – Environment Interactions

EORD State–of–the–Art: Gene – Environment Interactions

Steven Kleeberger PhD

2504 – FADDA State–of–the–Art: Role of Food Allergy and Patch Testing in Eosinophilic Esophagitis and Gastroenteritis

FADDA State–of–the–Art: Role of Food Allergy and Patch Testing in Eosinophilic Esophagitis and Gastroenteritis

Jonathan Spergel MD PhD FAAAAI

2505 – HCEDQ State–of–the–Art: Insight Into Disparities in Pediatric Asthma

Is the Hygiene Hypothesis Valid in the Inner City? Understanding Environmental and Genetic Risk Factors

Andrew Liu MD FAAAAI

Preventing Asthma Hospitalizations in Inner – City and Minority Children

Glenn Flores MD FAAP

2506 – MAAI State–of–the–Art: The Central Role of the TSLP OX40 Ligand Pathway in Polarizing Allergic Immune Responses

MAAI State–of–the–Art: The Central Role of the TSLP OX40 Ligand Pathway in Polarizing Allergic Immune Responses

Yong – Jun Liu MD PhD

2507 – RSOD State–of–the–Art: Obstructive Sleep Apnea: Inflammatory Effects

RSOD State–of–the–Art: Obstructive Sleep Apnea: Inflammatory Effects

Qutayba Hamid MD PhD FAAAAI

2511 – Reimbursement Matters: Use the Perfect CPT Codes

Reimbursement Matters: Use the Perfect CPT Codes

Anjuli Nayak MD FAAAAI

Reimbursement Matters: Use the Perfect CPT Codes

Teresa Thompson CPC CMSCS CCC

2512 – Regulatory T Cells

Regulatory T Cells

Talal Chatila MD

Regulatory T Cells

Troy Torgerson MD PhD

2513 – Mycoplasma, Pneumococcus and Viral Illness: Their Role in Asthma?

Mycoplasma, Pneumococcus and Viral Illness: Their Role in Asthma?

Jack Routes MD FAAAAI

Mycoplasma, Pneumococcus and Viral Illness: Their Role in Asthma?

Monica Kraft MD

2514 – What is the Best Way to Follow Asthma Control?

What is the Best Way to Follow Asthma Control?

Christine Sorkness PharmD

What is the Best Way to Follow Asthma Control?

John Oppenheimer MD

2515 – Monoclonal Antibody Therapy of Disease

Monoclonal Antibody Therapy of Disease

John Sundy MD PhD

Monoclonal Antibody Therapy of Disease

Terry Harville MD PhD

2516 – Hypereosinophilia and Eosinophilia Disease

Hypereosinophilia and Eosinophilia Disease

Gerald Gleich MD FAAAAI

Hypereosinophilia and Eosinophilia Disease

Peter Weller MD FAAAAI

2517 – The Role of Long Acting Beta Agonists in Exercise Induced Bronchospasm

The Role of Long Acting Beta Agonists in Exercise Induced Bronchospasm

Donald Cockcroft MD FAAAAI

The Role of Long Acting Beta Agonists in Exercise Induced Bronchospasm

Timothy Craig DO FAAAAI

2518 – Sick Building Syndrome: Does it Really Exist and How Do You Treat It?

Sick Building Syndrome: Does it Really Exist and How Do You Treat It?

Dennis Shusterman MD MPH

Sick Building Syndrome: Does it Really Exist and How Do You Treat It?

James Scott PhD

2519 – Desensitization Protocols for Antibiotics and Other Medications

Desensitization Protocols for Antibiotics and Other Medications

Michael Weiss MD FAAAAI

Desensitization Protocols for Antibiotics and Other Medications

Mariana Castells MD PhD FAAAAI

2520 – Chronic Urticaria/Angioedema Update

Chronic Urticaria/Angioedema Update

Allen Kaplan MD FAAAAI

Chronic Urticaria/Angioedema Update

Sarbjit Saini MD FAAAAI

2521 – Newer Treatment Options in CRS

Newer Treatment Options in CRS

Daniel Hamilos MD FAAAAI

Newer Treatment Options in CRS

Michael Kaliner MD FAAAAI

2522 – Aspirin – Exacerbated Respiratory Disease: A Model for Eicosanoid Biology in Humans

Aspirin – Exacerbated Respiratory Disease: A Model for Eicosanoid Biology in Humans

Andrew Szczeklik MD PhD

Aspirin – Exacerbated Respiratory Disease: A Model for Eicosanoid Biology in Humans

Tak Lee MD FAAAAI

2523 – Stress and Asthma: Immune Mechanisms of Increased Susceptibility to Allergic Sensitization

Stress and Asthma: Immune Mechanisms of Increased Susceptibility to Allergic Sensitization

Angela Haczku MD PhD

Stress and Asthma: Immune Mechanisms of Increased Susceptibility to Allergic Sensitization

Rosalind Wright MD MPH

2524 – Nose – Lung Interactions: Does Treating the Nose Ameliorate Asthma? Current Controversies

Nose – Lung Interactions: Does Treating the Nose Ameliorate Asthma? Current Controversies

Jonathan Corren MD

Nose – Lung Interactions: Does Treating the Nose Ameliorate Asthma? Current Controversies

Alkis Togias MD

2525 – Specific Aspects of Chronic Sinusitis in Children: Diagnosis, Treatment and Prognosis

Specific Aspects of Chronic Sinusitis in Children: Diagnosis, Treatment and Prognosis

Fuad Baroody MD FAAAAI

Specific Aspects of Chronic Sinusitis in Children: Diagnosis, Treatment and Prognosis

Martin Wagenmann MD FAAAAI

2:00 – 3:15pm

2621 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Allergic Rhinitis to Asthma: The Spectrum of One Airway Disease

The Role of Upper Airway Disease (Rhinitis/Sinusitis) in the Pathogenesis of Asthma

James Gern MD FAAAAI

Therapeutic Interventions for Patients with Both Upper and Lower Airway Disease

David Khan MD FAAAAI

2622 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: The Stinging Insects: Identification, Patient Evaluation & Treatment

Overview of the Stinging Insects, Their Habitats and Habits

Ginger LaBelle NP

Evaluation of Stinging Insect Allergy and the Indications for Initiating and Completing Venom Immunotherapy

Robert Reisman MD FAAAAI

3:30 – 4:30pm

2701 – Keynote Address: Emerging and Re – Emerging Infectious Diseases: The Perpetual Challenge to Global Health

Keynote Address: Emerging and Re – Emerging Infectious Diseases: The Perpetual Challenge to Global Health

Anthony Fauci MD

4:45 – 6:00pm

2801 – Primum Non Nocere: Risk/Benefits for Anti – Asthma Therapy

Moderator

I. Leonard Bernstein MD FAAAAI

Beta Receptor Polymorphisms

Michael Wechsler MD

Allergy Immunotherapy

John Oppenheimer MD

Glucocorticosteroids

Richard Ahrens MD

2802 – Difficult and Interesting Cases in Asthma

Difficult and Interesting Cases in Asthma

David Lang MD FAAAAI

Difficult and Interesting Cases in Asthma

Leonard Bacharier MD FAAAAI

Difficult and Interesting Cases in Asthma

William Calhoun MD FAAAAI

Difficult and Interesting Cases in Asthma

Giselle Mosnaim MD MS FAAAAI

2803 – Pharmacogenetic Responses in Asthma: Is it Time for Genetic Testing?

The Clinical Consequences of Beta – 2 Receptor Polymorphisms

Eugene Bleecker MD FAAAAI

The Genetics of Corticosteroid Responses: State of the Art

Scott Weiss MD MS

Can Understanding Pharmacogenetics Improve Asthma Control?

Christine Sorkness PharmD

2804 – Nuances of Pulmonary Function from Asthma to COPD

Nuances of Pulmonary Function from Asthma to COPD

John Weiler MD FAAAAI

Nuances of Pulmonary Function from Asthma to COPD

Mark Sands MD FAAAAI

Nuances of Pulmonary Function from Asthma to COPD

Donald Tashkin MD

2805 – Reassessing Impact of Early Environmental Exposures on Development and Prevention of Allergic Disease

Childhood Exposures in Developed Nations: Is There Something Missing?

Erika Von Mutius MD MSc

Global Allergen Reduction vs. Routine Environmental Control: Is there a Difference in Primary and Secondary Prevention?

Frederic De Blay MD

Probiotics: Is it Time to Start Using Them?

John Bienenstock MD FAAAAI

2806 – Smoking Cessation

Adverse Effects of Active and Passive Smoke Exposure on Asthm